Anxiety Disorder Associated with the COVID-19 Pandemic Causes Deterioration of Blood Pressure Control in Primary Hypertensive Patients

dc.authoridKARADUMAN, AHMET/0000-0002-4039-1259
dc.authoridCakmak, Ender Ozgun/0000-0001-6767-6935
dc.authoridcelik, mehmet/0000-0003-0364-2239
dc.authoridYILMAZ, YUSUF/0000-0002-6676-2740
dc.contributor.authorCelik, Mehmet
dc.contributor.authorYılmaz, Yusuf
dc.contributor.authorKaragoz, Ali
dc.contributor.authorKahyaoglu, Muzaffer
dc.contributor.authorCakmak, Ender Ozgun
dc.contributor.authorKup, Ayhan
dc.contributor.authorCelik, Fatma Betul
dc.date.accessioned2025-05-10T19:53:05Z
dc.date.issued2021
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: The new coronavirus disease (COVID-19) has spread rapidly all over the world and caused anxiety disorders. Recent studies have also shown that the prevalence of depression and anxiety increased during the COVID-19 outbreak. We aimed to evaluate the anxiety and depression levels during the pandemic and identify the effect of pandemic-related stress on blood pressure (BP) control in primary hypertensive patients.Method: A total of 142 patients with primary hypertension (HT) who continued to use the same antihypertensive drugs before and during the pandemic were included in the study. Twenty-four -hour Ambulatory Blood Pressure Monitoring (ABPM) and the Hospital Anxiety and Depression Scale (HADS) questionnaire were applied to patients. We retrospectively reviewed 24-h ABPM records of the same patients for the year before the pandemic.Results: Daytime, nighttime and 24 -hour-systolic blood pressure (SBP) levels as well as daytime, nighttime, and 24- hour-diastolic blood pressure (DBP) levels , were significantly elevated during the COVID-19 outbreak compared to the pre-pandemic period (p<0.001). Higher HADS-A scores (HADS-A >= 7) were significantly associated with much greater increase in BP compared to the patients with lower HADS-A scores.Conclusion: Psychological stress due to the COVID-19 outbreak led to worsening of the regulation of BP in controlled hypertensive patients whose antihypertensive treatments did not change.
dc.identifier.doi10.5222/MMJ.2021.08364
dc.identifier.endpage90
dc.identifier.issn2149-2042
dc.identifier.issn2149-4606
dc.identifier.issue2
dc.identifier.pmid34239759
dc.identifier.scopus2-s2.0-85109300881
dc.identifier.scopusqualityQ2
dc.identifier.startpage83
dc.identifier.trdizinid487144
dc.identifier.urihttps://doi.org/10.5222/MMJ.2021.08364
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/487144
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12632
dc.identifier.volume36
dc.identifier.wosWOS:001109453000007
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.ispartofMedeniyet Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectCOVID-19
dc.subjectpandemic
dc.subjecthypertension
dc.subjectanxiety
dc.titleAnxiety Disorder Associated with the COVID-19 Pandemic Causes Deterioration of Blood Pressure Control in Primary Hypertensive Patients
dc.typeArticle

Dosyalar